1. Fang, Fang, Zhuang, Pei, Feng, Xue, Ye, Jiangbin, Hu, Yang. 2022. NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function. In Molecular therapy : the journal of the American Society of Gene Therapy, 30, 1421-1431. doi:10.1016/j.ymthe.2022.01.035. https://pubmed.ncbi.nlm.nih.gov/35114390/
2. Yu, Jianjun, Meng, Jianhong, Qin, Zhengwei, Wang, Yanjun, Min, Dongmei. 2023. Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson's disease. In Journal of neuroinflammation, 20, 117. doi:10.1186/s12974-023-02782-1. https://pubmed.ncbi.nlm.nih.gov/37208728/
3. Tribble, James R, Jöe, Melissa, Varricchio, Carmine, Brancale, Andrea, Williams, Pete A. 2024. NMNAT2 is a druggable target to drive neuronal NAD production. In Nature communications, 15, 6256. doi:10.1038/s41467-024-50354-5. https://pubmed.ncbi.nlm.nih.gov/39048544/
4. Challa, Sridevi, Khulpateea, Beman R, Nandu, Tulip, Lea, Jayanthi S, Kraus, W Lee. 2021. Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancers. In Cell, 184, 4531-4546.e26. doi:10.1016/j.cell.2021.07.005. https://pubmed.ncbi.nlm.nih.gov/34314702/
5. Liu, Pingting, Huang, Haoliang, Fang, Fang, Sun, Yang, Hu, Yang. 2021. Neuronal NMNAT2 Overexpression Does Not Achieve Significant Neuroprotection in Experimental Autoimmune Encephalomyelitis/Optic Neuritis. In Frontiers in cellular neuroscience, 15, 754651. doi:10.3389/fncel.2021.754651. https://pubmed.ncbi.nlm.nih.gov/34707482/
6. Cheng, Xiang-Shu, Zhao, Kun-Peng, Jiang, Xia, Wang, Jian-Zhi, Zhou, Xin-Wen. . Nmnat2 attenuates Tau phosphorylation through activation of PP2A. In Journal of Alzheimer's disease : JAD, 36, 185-95. doi:10.3233/JAD-122173. https://pubmed.ncbi.nlm.nih.gov/23579329/
智鼠故事 
